Looking to stay ahead in the world of drug discovery? Join Princeton Innovation Center BioLabs for the Proteomics-Driven Drug Discovery event on Monday, June 10 | 12:00 pm–1:30 pm! Learn from leading experts and gain insights that will supercharge your research and development efforts. Don't miss out! https://lnkd.in/e7vNbEhB
Princeton Entrepreneurship Council’s Post
More Relevant Posts
-
Meet the Chemaxon ChemTalks Powerhouse Speakers! We're thrilled to introduce some of the incredible minds leading the charge at ChemTalks! These industry leaders will share their groundbreaking insights on bridging silos and accelerating early-stage drug discovery. Thrasyvoulos Karydis, Co-founder, Chief Technology Officer, DeepCure: AI-driven drug discovery beyond kinases: How to NOT get trapped in a local minimum when designing drugs for intractable targets Jessica Lanini Senior Expert, Data Science, Novartis Institutes for BioMedical Research: AI advancing drug discovery research in the pharmaceutical industry and academia Timur Madzhidov, Senior Product Manager in Chemistry Innovation, Elsevier: Unlocking the power of data from disparate sources: Elsevier’s journey toward accurate reaction outcome predictions ️ Adrian Stevens, Stevens Chief Product Officer, Chemaxon: Developing new science and technologies that aid future drug discovery needs Becky Upton, President, Pistoia Alliance: Finding the best way to use large language models in biological R&D These are just a few of the amazing speakers joining us at ChemTalks! Don't miss this FREE opportunity to gain cutting-edge knowledge and network with top minds in drug discovery. Register here: https://lnkd.in/gPPX5dYU #Chemtalks #DrugDiscovery #ResearchandDevelopment #ArtificialIntelligence
To view or add a comment, sign in
-
Why are #organoids becoming increasingly popular in drug discovery, and how can you integrate these powerful cell models into your research? Our Essential Guide to Organoids in Drug Discovery is your go-to resource. It covers the history, current role, and future impact of organoids in drug discovery. You'll discover how organoids can be used across various applications and how new technologies are breaking down barriers to using these models in the #drugdiscovery process. Read more: https://lnkd.in/eE5jYpyE
To view or add a comment, sign in
-
I am excited to share my review article titled **"Pharmacophore-Based Drug Design: Bridging Molecular Insights and Therapeutic Innovations."** This article explores the pharmacophore concept and its pivotal role in computer-aided drug design, including applications in virtual screening and lead optimization. It highlights the integration of pharmacophore modeling with advanced computational techniques, showcasing its impact on drug discovery efficiency and innovation.
To view or add a comment, sign in
-
When mapping out and attempting to understand the complexity of a biological network, assessing the data points in isolation is limiting and makes identifying novel therapeutic targets challenging. However, when working with a knowledge graph, a network of data points is created, resulting in a 360 view of your protein or compound that provides insights to identify better targets. ONTOFORCE works with large pharma companies and biotechs alike to address the challenge of data in isolation to ultimately speed up target identification. Hear more from e-therapeutic’s Head of Discovery Biology, James Longden, on the biological complexity of protein-protein interaction and how ONTOFORCE’s knowledge discovery platform, DISQOVER, is supporting optimized, AI-driven target identification: https://lnkd.in/eZhuTHJp
e-therapeutic’s James Longden Head of Discovery Biology
To view or add a comment, sign in
-
Now available on demand! Watch our recent #webinar discussing scientific innovations that are expanding the druggable space and enabling greater discovery of novel targets: https://bit.ly/3xKrkfz Presenters Dr. Mo Jain and Dr. Jonathan Usuka answer questions such as: ▶️ What therapeutic opportunities await #pharma developers now with innovative new drug modalities that can engage previously difficult-to-drug proteins? ▶️ How are technological advances in mass spectrometry changing the landscape of discovery #proteomics for target ID? ▶️ How is AI-based #multiomics data integration able to help prioritize the best targets to pursue? Download the full recording to hear these answers and more! https://bit.ly/3xKrkfz #targetidentification #targetvalidation #proteintargets
To view or add a comment, sign in
-
Accelerate your drug discovery process. Our new whitepaper helps you easily navigate early candidate selection during translational research using Biacore SPR systems. Make more informed decisions and minimize the risk of failure. Download our whitepaper to learn more. https://lnkd.in/g3MeC4rV #drugdiscovery #translationalresearch #translationalmedicine #SPR
DOWNLOAD: Enhance the drug discovery process for translational scientists
cytiva.link
To view or add a comment, sign in
-
🌟 𝗨𝗻𝗹𝗼𝗰𝗸𝗶𝗻𝗴 𝗡𝗲𝘄 𝗣𝗼𝘀𝘀𝗶𝗯𝗶𝗹𝗶𝘁𝗶𝗲𝘀 𝗶𝗻 𝗗𝗿𝘂𝗴 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝘄𝗶𝘁𝗵 𝗠𝗮𝘀𝘀 𝗦𝗽𝗲𝗰𝘁𝗿𝗼𝗺𝗲𝘁𝗿𝘆🌟 At #SCIEX, we're proud to be at the forefront of technological advancements that are transforming the roles of CDMOs and CROs in the drug development life cycle. 🚀 As highlighted in a recent article by Pharma's Almanac, our very own Kean Woodmansey, Senior Global Market Development Manager, Pharma at SCIEX, commented on how cutting-edge tools like high-resolution mass spectrometry (HRMS) and tandem MS/MS are enabling precise identification and structural analysis of complex molecules. Our advanced techniques, including electron-activated dissociation (EAD), offer unparalleled insights into biomolecule quantitation and structural elucidation—paving the way for more targeted and effective therapies. By integrating AI and machine learning with mass spectrometry data, we're helping our partners optimize drug discovery and manufacturing, making the process more efficient and informed. Techniques like native mass spectrometry also allow the study of biomolecules in their natural state, critical for advancing biologics and personalized medicine. As technology evolves, we're excited to continue driving innovation, enhancing the scope and impact of CDMOs and CROs in the discovery of novel medicines. 💡 𝗥𝗲𝗮𝗱 𝗺𝗼𝗿𝗲: https://bit.ly/4cnSS8V #DrugDevelopment #MassSpectrometry #CDMO #CRO #PharmaInnovation #SCIEX #DanaherNews
To view or add a comment, sign in
-
Accelerate your drug discovery process. Our new whitepaper helps you easily navigate early candidate selection during translational research using Biacore SPR systems. Make more informed decisions and minimize the risk of failure. Download our whitepaper to learn more. https://lnkd.in/gKTK9NFQ #drugdiscovery #translationalresearch #translationalmedicine #SPR
DOWNLOAD: Enhance the drug discovery process for translational scientists
cytiva.link
To view or add a comment, sign in
-
AI for Good: ALS drug discovery The Details: ALS, known also as Lou Gehrig’s disease, doesn’t currently have a cure. Because of this, it has become an area of focus for some biotech and pharmaceutical companies. Why it matters: “For years, researchers have heavily relied on animal or cell models to identify new targets, in a way that oversimplifies the enormous complexity of human biology, particularly for diseases like ALS,” Dr. Robert H. Scannevin, Verge’s chief scientific officer, said in a statement. “The Converge platform starts with, and integrates, human data and human model systems throughout discovery and development,” providing “unique insights into the biological underpinnings of ALS.” #clinicalresearch #ALS
To view or add a comment, sign in
-
Accelerate your drug discovery process. Our new whitepaper helps you easily navigate early candidate selection during translational research using Biacore SPR systems. Make more informed decisions and minimize the risk of failure. Download our whitepaper to learn more. https://lnkd.in/g8qW2KTE #drugdiscovery #translationalresearch #translationalmedicine #SPR
DOWNLOAD: Enhance the drug discovery process for translational scientists
cytiva.link
To view or add a comment, sign in
2,196 followers